SEC Form 4 · accession 0001179110-15-008521
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shane William Charles Kovacs
Officer — Chief Financial Officer
Period of report
May 22, 2015
Accepted (ET)
May 22, 2015 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2015 | M | 60,375 | $10.85 | A | 72,725 | D | |
| Common Stock | May 22, 2015 | M | 18,616 | $27.05 | A | 91,341 | D | |
| Common StockF2 | May 22, 2015 | S | 64,041 | $55.26 | D | 27,300 | D | |
| Common StockF3 | May 22, 2015 | S | 18,450 | $55.93 | D | 8,850 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $10.85 | May 22, 2015 | M | 60,375 | D | — | May 21, 2023 | Common Stock | 60,375 | 65,625 | D |
| Stock Option (Right to Buy)F5 | $27.05 | May 22, 2015 | M | 18,616 | D | — | Jan 27, 2024 | Common Stock | 18,616 | 46,384 | D |
| Stock Option (Right to Buy)F6 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 85,600 | 85,600 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.73 to $55.72 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.73 to $56.48 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This option award was granted on May 22, 2013, with 25% of the shares underlying the option vested on May 22, 2014, and an additional 2.083% of the original number of shares underlying the option vesting on a monthly basis thereafter, beginning on June 30, 2014.
- F5This option award was granted on January 28, 2014, with 25% of the shares underlying the option vested on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
- F6This option award was granted on January 2, 2015, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.